Tal-Gan, Yftah - University of Nevada-Reno

个人简介

Postdoctoral Research Associate (2011-2014), University of Wisconsin-Madison (Helen E. Blackwell) Ph.D. (2011), The Hebrew University of Jerusalem (Chaim Gilon & Alexander Levitzki) M.S. (2006) The Hebrew University of Jerusalem (Chaim Gilon) MBA (2005), The Hebrew University of Jerusalem B.S. (2001), The Hebrew University of Jerusalem

研究领域

Research in the Tal-Gan laboratory will focus on the development of chemical-based tools to address important biological questions with potential therapeutic implications. There is a constant demand for new and improved chemical probes that can be utilized to study diverse biological systems, and peptides represent attractive tools for the generation of such probes. My lab will use peptides and their analogs to study important signaling pathways and develop novel drug-leads. Two main areas of research will be insulin and bacterial communication.

近期论文

查看导师新发文章（温馨提示：请注意重名现象，建议点开原文通过作者单位确认）

Tal-Gan, Y.; Stacy, D.M.; Blackwell, H.E. N-Methyl and Peptoid Scans of an Autoinducing Peptide Reveal New Structural Features Required for Inhibition and Activation of AgrC Quorum Sensing Receptors in Staphylococcus aureus. Chem. Commun. 2014, 50, 3000-3003. Broderick, A.H.; Stacy, D.M.; Tal-Gan, Y.; Kratochvil, M.J.; Blackwell, H.E.; Lynn, D.M. Surface Coatings that Promote Rapid Release of Peptide-Based AgrC Inhibitors for Attenuation of Quorum Sensing in Staphylococcus aureus. Adv. Healthcare Mater. 2014, 3, 97-105. Tal-Gan, Y.; Ivancic, M.; Cornilescu, G.; Cornilescu, C.C.; Blackwell, H.E. Structural Characterization of Native Autoinducing Peptides and Abiotic Analogs Reveals Key Features Essential for Activation and Inhibition of an AgrC Quorum Sensing Receptor in Staphylococcus aureus. J. Am. Chem. Soc. 2013, 135, 18436-18444. Tal-Gan, Y.; Stacy, D.M.; Foegen, M.K.; Koenig, D.W.; Blackwell, H.E. Highly Potent Inhibitors of Quorum Sensing in Staphylococcus aureus Revealed through a Systematic Synthetic Study of the Group-III Autoinducing Peptide. J. Am. Chem. Soc. 2013, 135, 7869-7882. Hurevich, M.; Ratner-Hurevich, M.; Tal-Gan, Y.; Shalev, D.E.; Ben-Sasson, S.Z.; Gilon, C. Backbone Cyclic Helix Mimetic of Chemokine (C-C Motif) Receptor 2: A Rational Approach for Inhibiting Dimerization of G Protein-Coupled Receptors. Bioorg. Med. Chem. 2013, 21, 3958-3966. Horwitz, E.; Tal-Gan, Y.; Temper, V.; Shapiro, M.; Gilon, C.; Hoffman, A. Chemical trapping of vancomycin - a potential strategy for preventing selection of vancomycin-resistant Enterococci. Microb. Drug Resist. 2012, 18, 109-115. Tal-Gan, Y.; Naveh, S.; Klein, S.; Moshel, O.; Levitzki, A.; Gilon, C. Studying Protein-Peptide Interactions Using Benzophenone Units: A Case Study of PKB/Akt and its Inhibitor PTR6154. Anal. Biochem. 2012, 421, 750-754. Naveh, S.; Tal-Gan, Y.; Ling, S.; Hoffman, A.; Holoshitz, J.; Gilon, C. Developing Potent Backbone Cyclic Peptides Bearing the Shared Epitope Sequence as Rheumatoid Arthritis Drug-Leads. Bioorg. Med. Chem. Lett. 2012, 22, 493-496. Tal-Gan, Y.; Freeman, N.S.; Klein, S.; Levitzki, A.; Gilon, C. Metabolic Stability of Peptidomimetics: N-Methyl and Aza Heptapeptide Analogs of a PKB/Akt Inhibitor. Chem. Biol. Drug Des. 2011, 78, 887-892. Tal-Gan, Y.; Hurevich, M.; Klein, S.; Ben-Shimon, A.; Rosenthal, D.; Hazan, C.; Shalev, D.E.; Niv, M.Y.; Levitzki, A.; Gilon, C. Backbone-Cyclic Peptide Inhibitors of Protein Kinase B (PKB/Akt). J. Med. Chem. 2011, 54, 5154-5164. Freeman, N.S.; Tal-Gan, Y.; Klein, S.; Levitzki, A.; Gilon, C. Microwave-Assisted Solid-Phase Aza-peptide Synthesis: Aza Scan of a PKB/Akt Inhibitor Using Aza-arginine and Aza-proline Precursors. J. Org. Chem. 2011, 76, 3078-3085. Tal-Gan, Y.; Freeman, N.S.; Klein, S.; Levitzki, A.; Gilon, C. Synthesis and structure-activity relationship studies of peptidomimetic PKB/Akt inhibitors: The significance of backbone interactions. Bioorg. Med. Chem. 2010, 18, 2976-2985. Hurevich, M.; Tal-Gan, Y.; Klein, S.; Barda, Y.; Levitzki, A.; Gilon, C. Novel method for the synthesis of urea backbone cyclic peptides using new Alloc protected glycine building units. J. Pept. Sci. 2010, 16, 178-185.